Skip to main content
. 2017 May 18;8(27):44639–44653. doi: 10.18632/oncotarget.17961

Table 1. Molecular characteristics and drug response of breast cancer cell lines.

Cell line ER status GRM1 expression RiluzoleIC50-μM (SD)* BAY 36-7620IC50-μM (SD)
MCF-7 Positive High 34.7 (9.9) 27.7 (5.8)
T-47D Positive Low 32.6 (4.1) 37.1 (7.6)
BT-474 Positive Low 24.2 (4.9) 20.8 (6.6)
MDA-MB-231 Negative High 62.4 (10.9) 41.0 (3.2)
Hs578T Negative Low 19.0 (2.7) 21.0 (2.8)
BT-549 Negative High 24.7 (10.6) 15.7 (1.3)

*Values in parentheses represent +/− standard deviation